Human Mesenchymal Stem Cell Therapy Reverses Su5416/Hypoxia-Induced Pulmonary Arterial Hypertension in Mice-Reference-Cited by-同舟云学术

Human Mesenchymal Stem Cell Therapy Reverses Su5416/Hypoxia-Induced Pulmonary Arterial Hypertension in Mice

Published:2018-12-06 Issue: Volume:9 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Alencar Allan K. N.,Pimentel-Coelho Pedro M.,Montes Guilherme C.,da Silva Marina de M. C.,Mendes Luiza V. P.,Montagnoli Tadeu L.,Silva Ananssa M. S.,Vasques Juliana Ferreira,Rosado-de-Castro Paulo Henrique,Gutfilen Bianca,Cunha Valéria do M. N.,Fraga Aline G. M.,Silva Patrícia M R e,Martins Marco Aurélio,Ferreira Tatiana Paula Teixeira,Mendes-Otero Rosalia,Trachez Margarete M.,Sudo Roberto T.,Zapata-Sudo Gisele

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference54 articles.

1. Stem cell therapy for bronchopulmonary dysplasia: bench to bedside translation.;Ahn;J. Korean Med. Sci.,2015

2. Activation of GPER ameliorates experimental pulmonary hypertension in male rats.;Alencar;Eur. J. Pharm. Sci.,2017

3. N-acylhydrazone derivative ameliorates monocrotaline-induced pulmonary hypertension through the modulation of adenosine AA2R activity.;Alencar;Int. J. Cardiol.,2014

4. Persistence and proliferation of human mesenchymal stromal cells in the right ventricular myocardium after intracoronary injection in a large animal model of pulmonary hypertension.;Badr Eslam;Cytotherapy,2017

5. Risk of tumorigenicity in mesenchymal stromal cell-based therapies–bridging scientific observations and regulatory viewpoints.;Barkholt;Cytotherapy,2013

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single high-dose intravenous injection of Wharton’s jelly-derived mesenchymal stem cell exerts protective effects in a rat model of metabolic syndrome;Stem Cell Research & Therapy;2024-06-05

2. Tumor Necrosis Factor-α–Induced Protein-8–like 2 Transfected Adipose-Derived Stem Cells Regulated the Dysfunction of Monocrotaline Pyrrole–Induced Pulmonary Arterial Smooth Muscle Cells and Pulmonary Arterial Endothelial Cells;Journal of Cardiovascular Pharmacology;2024-01

3. Stem cell therapy in pulmonary hypertension: current practice and future opportunities;European Respiratory Review;2023-09-27

4. Pharmacotherapy of refractory pulmonary arterial hypertension;Expert Opinion on Pharmacotherapy;2023-09-12

5. Mesenchymal Stem Cell–derived Nanovesicles as a Credible Agent for Therapy of Pulmonary Hypertension;American Journal of Respiratory Cell and Molecular Biology;2022-07